Drug Companies Pledge 240M COVID-19 Vaccine Doses
Tuesday, February 23, drug companies said that the United States can expect to see a total of 240 million doses of the COVID-19…
J&J Seeks Emergency Authorization for Single-Shot Vaccines
Pharmaceutical giant Johnson & Johnson submitted its single-shot coronavirus vaccine for emergency use authorization after the vaccine was shown to be robustly effective…
J&J to Provide 500M Doses of Vaccine for Poor Countries
Tuesday, December 8, US pharmaceutical giant Johnson & Johnson plans to provide 500 million doses of its coronavirus vaccine for poor countries once…
Johnson & Johnson Starts Two-Dose Trial COVID-19 Vaccine on U.K
Monday, November 16, Johnson & Johnson launched a new late-stage trial in Britain to test two-dose regimen of its COVID-19 candidate vaccine. The…
J&J Pauses Vaccine Trials Due to Unexplained Illness in Participants
Monday, October 12, Johnson & Johnson had temporarily paused its COVID-19 vaccine clinical trial due to an unexplained illness in a study participant.…
Johnson & Johnson’s Single-Dose Vaccine Enters Late-Stage Trials
Pharmaceutical titan Johnson & Johnson has begun its phase three trial testing its potential coronavirus vaccine in 60,000 people enrolled in the trial.…
J&J Plans 60k Subjects to Start COVID-19 Vaccine Trial in September
Johnson & Johnson plan to begin the largest, late-stage trial testing a potential coronavirus vaccine in September. The phase three trial would enroll…
Johnson & Johnson Strikes $6.5 Billion Deal for Momenta
Johnson & Johnson will buy Momenta Pharmaceuticals for about $6.5 billion to bolster its portfolio of treatments for autoimmune diseases. The deal gives…
J&J Starts Human Study of COVID-19 Vaccine after Promising Data
J&J kicked off human safety trials for its COVID-19 vaccine after a study in monkeys showed its best-performing vaccine candidate offered strong protection…
ASEAN HR TECH VENTURE SUMMIT 2018
REGISTER NOW 33% DISCOUNTSUMMIT PASS
Send this to a friend